サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1576971

ペースメーカーの世界市場の評価：移植可能性別、技術別、タイプ別、適応症別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Pacemakers Market Assessment, By Implantability, By Technology, By Type, By Indication, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日
ページ情報
英文 229 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.69円
ペースメーカーの世界市場の評価：移植可能性別、技術別、タイプ別、適応症別、エンドユーザー別、地域別、機会、予測（2017年～2031年）
出版日: 2024年10月25日
発行: Markets & Data
ページ情報: 英文 229 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のペースメーカーの市場規模は、2023年の50億6,000万米ドルから2031年に69億5,000万米ドルに達すると予測され、予測期間の2024年～2031年にCAGRで4.05%の成長が見込まれます。市場は、心血管疾患（CVD）の増加、新薬の市場参入、革新的な製品に対する規制当局の承認によって牽引されています。市場の大部分は上位5社によって独占されていますが、市場の成長率はより高くなると予測されます。

ペースメーカーは、不整脈患者の心臓リズムを円滑にするために心臓に留置される医療機器です。ペースメーカーの需要は大幅に増加しており、CVDの負担が増加していることから、今後さらに拡大すると予測されています。設計の最適化を通じて患者のコンプライアンスを向上させ、このようなデバイスのサイズを小さくすることを目的とした技術の進歩は、市場の成長率をさらに高めます。しかし、複数の促進要因が存在するにもかかわらず、市場は、このようなインプラントを使用する患者が直面している電池寿命の問題や、デバイスとそれを埋め込む手術に関連する高いコストのような課題に直面しています。さらに、頻繁な規制当局の承認と戦略的な製品投入が市場の活性化を維持し、さらなる拡大に寄与しています。2023年7月、BIOTRONIK SE & Co KGは、ペースメーカーAmvia Edgeと心臓再同期療法ペースメーカー（CRT-P）のポートフォリオがUSFDAの承認を取得したことを発表しました。Amvia Edgeは、市場最小のシングルチャンバーMRコンディショナルペースメーカーで、自動化されたワークフローの効率とともに、患者中心のユニークな臨床ソリューションを導入しています。

当レポートでは、世界のペースメーカー市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のペースメーカー市場の見通し（2017年～2031年）

  • 市場規模の分析と予測
    • 金額
    • 数量
  • 市場シェアの分析と予測
    • 移植可能性別
    • 技術別
    • タイプ別
    • 適応症別
    • エンドユーザー別
    • 地域別
    • 市場シェア分析：企業別（金額）（上位5社とその他 - 2023年）
  • 市場マップ分析（2023年）
    • 移植可能性別
    • 技術別
    • タイプ別
    • 適応症別
    • エンドユーザー別
    • 地域別

第5章 北米のペースメーカー市場の見通し（2017年～2031年）

  • 市場規模の分析と予測
    • 金額
    • 数量
  • 市場シェアの分析と予測
    • 移植可能性別
    • 技術別
    • タイプ別
    • 適応症別
    • エンドユーザー別
    • シェア：国別
  • 各国の市場の評価
    • 米国のペースメーカー市場の見通し（2017年～2031年）
    • カナダ
    • メキシコ

第6章 欧州のペースメーカー市場の見通し（2017年～2031年）

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • ポーランド

第7章 アジア太平洋のペースメーカー市場の見通し（2017年～2031年）

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第8章 南米のペースメーカー市場の見通し（2017年～2031年）

  • ブラジル
  • アルゼンチン

第9章 中東・アフリカのペースメーカー市場の見通し（2017年～2031年）

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ
  • イスラエル

第10章 需給分析

第11章 輸入と輸出の分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

  • 市場促進要因
  • 市場の課題

第17章 市場の動向と発展

第18章 規制枠組みとイノベーション

  • 臨床試験
  • 規制当局の承認

第19章 特許情勢

第20章 ケーススタディ

第21章 競合情勢

  • マーケットリーダー上位5社の競合マトリクス
  • 上位5社のSWOT分析
  • 主要企業上位10社の情勢
    • Medtronic plc
    • Abbott Laboratories
    • BOSTON SCIENTIFIC CORPORATION
    • BIOTRONIK SE & Co KG
    • Lepu Medical Technology (Beijing) Co., Ltd.
    • OSYPKA MEDICAL GmbH
    • MEDICO S.R.L.
    • MicroPort Scientific Corporation
    • Shree Pacetronix Ltd.
    • LivaNova PLC

第22章 戦略的推奨

第23章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 4. Global Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 6. Global Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 7. Global Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 8. Global Pacemaker Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 11. North America Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 12. North America Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 13. North America Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 14. North America Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 15. North America Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 16. North America Pacemaker Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 19. United States Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 20. United States Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 21. United States Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 22. United States Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 23. United States Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 24. Canada Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 26. Canada Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 27. Canada Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 28. Canada Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 29. Canada Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 30. Canada Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 31. Mexico Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 33. Mexico Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 34. Mexico Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 35. Mexico Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 36. Mexico Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 37. Mexico Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 38. Europe Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 40. Europe Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 41. Europe Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 42. Europe Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 43. Europe Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 44. Europe Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 45. Europe Pacemaker Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 48. Germany Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 49. Germany Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 50. Germany Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 51. Germany Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 52. Germany Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 53. France Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 55. France Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 56. France Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 57. France Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 58. France Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 59. France Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 60. Italy Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 62. Italy Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 63. Italy Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 64. Italy Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 65. Italy Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 66. Italy Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 67. United Kingdom Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 69. United Kingdom Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 70. United Kingdom Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 71. United Kingdom Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 72. United Kingdom Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 73. United Kingdom Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 74. Russia Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 76. Russia Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 77. Russia Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 78. Russia Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 79. Russia Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 80. Russia Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 81. Netherlands Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Netherlands Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 83. Netherlands Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 84. Netherlands Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 85. Netherlands Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 86. Netherlands Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 87. Netherlands Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 88. Spain Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Spain Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 90. Spain Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 91. Spain Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 92. Spain Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 93. Spain Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 94. Spain Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 95. Turkey Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Turkey Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 97. Turkey Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 98. Turkey Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 99. Turkey Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 100. Turkey Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 101. Turkey Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 102. Poland Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. Poland Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 104. Poland Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 105. Poland Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 106. Poland Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 107. Poland Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 108. Poland Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 109. South America Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. South America Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 111. South America Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 112. South America Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 113. South America Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 114. South America Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 115. South America Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 116. South America Pacemaker Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Brazil Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 119. Brazil Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 120. Brazil Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 121. Brazil Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 122. Brazil Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 123. Brazil Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 124. Argentina Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Argentina Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 126. Argentina Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 127. Argentina Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 128. Argentina Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 129. Argentina Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 130. Argentina Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 131. Asia-Pacific Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Asia-Pacific Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 133. Asia-Pacific Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 134. Asia-Pacific Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 135. Asia-Pacific Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 136. Asia-Pacific Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 137. Asia- Pacific Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 138. Asia-Pacific Pacemaker Market Share (%), By Country, 2017-2031F
  • Figure 139. India Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. India Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 141. India Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 142. India Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 143. India Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 144. India Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 145. India Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 146. China Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 147. China Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 148. China Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 149. China Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 150. China Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 151. China Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 152. China Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 153. Japan Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 154. Japan Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 155. Japan Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 156. Japan Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 157. Japan Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 158. Japan Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 159. Japan Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 160. Australia Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 161. Australia Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 162. Australia Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 163. Australia Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 164. Australia Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 165. Australia Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 166. Australia Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 167. Vietnam Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Vietnam Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 169. Vietnam Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 170. Vietnam Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 171. Vietnam Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 172. Vietnam Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 173. Vietnam Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 174. South Korea Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 175. South Korea Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 176. South Korea Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 177. South Korea Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 178. South Korea Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 179. South Korea Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 180. South Korea Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 181. Indonesia Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. Indonesia Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 183. Indonesia Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 184. Indonesia Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 185. Indonesia Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 186. Indonesia Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 187. Indonesia Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 188. Philippines Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 189. Philippines Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 190. Philippines Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 191. Philippines Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 192. Philippines Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 193. Philippines Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 194. Philippines Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 195. Middle East & Africa Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Middle East & Africa Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 197. Middle East & Africa Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 198. Middle East & Africa Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 199. Middle East & Africa Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 200. Middle East & Africa Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 201. Middle East & Africa Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 202. Middle East & Africa Pacemaker Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 204. Saudi Arabia Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 205. Saudi Arabia Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 206. Saudi Arabia Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 207. Saudi Arabia Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 208. Saudi Arabia Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 209. Saudi Arabia Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 210. UAE Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 211. UAE Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 212. UAE Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 213. UAE Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 214. UAE Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 215. UAE Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 216. UAE Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 217. South Africa Pacemaker Market, By Value, In USD Billion, 2017-2031F
  • Figure 218. South Africa Pacemaker Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 219. South Africa Pacemaker Market Share (%), By Implantability, 2017-2031F
  • Figure 220. South Africa Pacemaker Market Share (%), By Technology, 2017-2031F
  • Figure 221. South Africa Pacemaker Market Share (%), By Type, 2017-2031F
  • Figure 222. South Africa Pacemaker Market Share (%), By Indication, 2017-2031F
  • Figure 223. South Africa Pacemaker Market Share (%), By End-user, 2017-2031F
  • Figure 224. By Implantability Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Indication Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX12167

Global pacemaker market is projected to witness a CAGR of 4.05% during the forecast period 2024-2031, growing from USD 5.06 billion in 2023 to USD 6.95 billion in 2031. The market for cardiac pacemakers is driven by growing cardiovascular diseases (CVD), novel drug entry into the market, and regulatory approvals for innovative products. The growth of this market is expected to be at a higher rate while the major market is served by the top 5 market players.

Pacemakers are the medical devices placed in the human heart to facilitate the cardiac rhythm in arrhythmic patients. The demand for pacemakers is rising significantly and with the growing CVD burden, it is anticipated to grow further in the future. Technological advances aim to improve patient compliance through design optimization and reducing the size of such devices further enhance the growth rate of the market. However, despite the presence of several driving forces, the market faces challenges like the high cost associated with the device and the procedure to implant it, along with the battery life issue being faced by patients with such implants. Furthermore, frequent regulatory approvals and strategic product launches keep the market active and help with further expansion. In July 2023, BIOTRONIK SE & Co KG announced the receipt of USFDA approval for its portfolio of Amvia Edge pacemakers and cardiac resynchronization therapy pacemakers (CRT-P), which highlights BIOTRONIK's latest innovation in cardiac rhythm management. Amvia Edge is the smallest single-chamber MR conditional pacemaker in the market and introduces a unique set of patient-centric clinical solutions coupled with automated workflow efficiency.

Growing Prevalence of CVD Boosts the Demand for Pacemakers

Demand for pacemakers is increasing due to the high prevalence of CVD. One very important cause for this increasing incidence is the aging population, characterized primarily by a sedentary lifestyle and poor diet. With new technology applied, the development of the pacemaker has heightened, and it is more appealing to patients as well as healthcare providers. As the awareness of CVD and its risks grows across the world, with better healthcare access, the market of pacemakers will continue to grow. It reflects the pressing need for innovative solutions in cardiovascular care with a focus on improvement in patient outcomes and quality of life. For instance, according to an article published in the European Heart Journal in November 2023, from 2010 to 2021, almost 114 thousand pacemakers were implanted. The corresponding statistics for single-chamber, double-chamber, and biventricular types make up 27.9%, 67.4%, and 4.6%, respectively. More men get a pacemaker implanted in them than women-more men get a pacemaker, as the distributions show (56.9% of men vs 43.1% were women). This trend is increasing every year. While 55.3% of the men were registered in 2010, in 2021, it will be 57.8%. The average age at the time of first pacemaker implantation is 76 years (75 years for men, 77 years for women). The average age at primary implantation increased by 1 year from 2010 to 2021 from 75.3 years to 76.3 years.

Emphasis on Reducing Size of Pacemakers Drives the Market

One major problem with pacemakers is their design and size, along with the set of mandatory precautions they come with. To overcome such challenges, several market players and researchers have come up with novel designs and initiatives to reduce its size to enhance patient compliance. Miniaturization decreases the level of discomfort patients experience since it will reduce the invasiveness and even the time taken to recover after implantation. Devices of even smaller sizes would improve aesthetic acceptance because they can be hardly observable under the skin. Technological advancement offers a provision for extra functionalities in compact configurations like remote monitoring and efficiency in battery use. Therefore, with this aspect of consideration, demand for small pacemakers would rise. For instance, in January 2024, Medtronic plc announced the receipt of the CE (Conformite Europeenne) Mark for its Micra AV2 and Micra VR2 pacemakers. These are the next generation of Medtronic's industry-leading miniature, leadless pacemakers. The Micra AV2 and Micra VR2 are the world's smallest pacemakers. They offer longer battery life and easier programming compared to previous Micra pacemakers, while still providing the many benefits of leadless pacing, such as reduced complications compared to traditional pacemakers. With approximately 40% more battery life compared to previous generations, Medtronic estimates that the battery life of the Micra AV2 and Micra VR2 is nearly 16 and 17 years, respectively.

Dominance of Arrhythmia Indication in Pacemaker Market

The Arrhythmia indication segment is anticipated to dominate the pacemaker market owing to the high prevalence of arrhythmia worldwide coupled with the high efficacy of pacemakers to correct the heart rhythm. These conditions are increasingly common due to factors like aging populations, sedentary lifestyles, and rising rates of chronic diseases. Pacemakers play a crucial role in managing these arrhythmias by ensuring the heart maintains a regular rhythm, which is essential for effective blood circulation. For instance, an article published in The Lancet Journal in February 2024 reported that Atrial fibrillation (AF) is the most common cardiac arrhythmia, with approximately 1.5-2% prevalence among adults in Europe, with expected further increase to 9.5% in individuals above 65 years by 2060. AF is also a significant threat since it is one of the major causes of stroke, dementia, heart failure, and premature death, which is all relevant to the growing elderly population, as well as healthcare systems.

North America Dominates the Pacemaker Market

North America is anticipated to be the leading region with the highest market share in the pacemaker market. The high incidence of cardiovascular diseases in the region leads to more demand for cardiac devices. Moreover, the prevalence of heart rhythm disorders among an aging population, along with escalating rates of obesity and sedentary lifestyles, is also the major cause. With advanced health infrastructure and high expenditure on healthcare, it is easier for patients in the United States and Canada to access advanced medical technology, such as pacemakers. Proper support from regulatory mechanisms and a strong network of care providers promote access to the necessary medical assistance as soon as possible for patients. Furthermore, the increased awareness among the public about the importance of heart care and preventive measures strengthens the growth of the pacemaker market in North America. For instance, according to The University of Texas Southwestern Medical Center, approximately 3 million people in the United States live with a pacemaker, which is a battery-powered device implanted in the chest to help maintain the proper heartbeat rate. Every year, around 200,000 of these devices are implanted in the United States for patients who have bradycardia or abnormal heart rhythms.

Future Market Scenario (2024- 2031F)

Leadless pacemakers are the latest inventions that are revolutionizing the pacemaker market, creating futuristic developments through a few key innovations. The burden of traditional leads that connect the device to the heart has been abolished in leadless pacemakers, thereby giving way to some greatly valued benefits, including reduced risk of complications and improved patient comfort. It also simplifies the implantation procedure, hence having a potential and faster recovery time with lower chances of infection. In addition, leadless technology opens the possibilities for more advanced functionalities like remote monitoring as well as advanced diagnostics, through which healthcare providers can treat their patients better. For instance, in July 2024, Abbott announced that the USFDA approved its AVEIR dual chamber (DR) leadless pacemaker system, which is the world's first dual chamber leadless pacing system that can be used to treat patients with arrhythmia. The approval significantly increases access to leadless pacing for millions of people across the United States, as more than 80% of those in need of a pacemaker require pacing in both the right atrium and right ventricle of the heart.

Key Players Landscape and Outlook

The pacemaker market is quite consolidated with a very limited number of market players and a major market being sabotaged by Medtronic plc. The market players in this segment are consistently innovating technology to create more advanced pacemakers to improve patient compliance. The market has seen regulatory approvals and some deals for market growth, however, the most notable acquisition dates back to the year 2017, when Abbott Laboratories acquired St. Jude Medical to enhance its market share in the pacemaker market.

In June 2024, Boston Scientific Corporation, a leading manufacturer of pacemakers, announced a definitive agreement to acquire Silk Road Medical, Inc., a medical device company that has developed an innovative platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR). The acquisition is worth approximately USD 1.16 billion.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Pacemaker Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Implantability
      • 4.2.1.1. Implantable
      • 4.2.1.2. External
    • 4.2.2. By Technology
      • 4.2.2.1. Single Chamber Pacemaker
      • 4.2.2.2. Dual Chamber Pacemaker
      • 4.2.2.3. Biventricular/CRT Pacemaker
    • 4.2.3. By Type
      • 4.2.3.1. Conventional
      • 4.2.3.2. MRI Compatible
    • 4.2.4. By Indication
      • 4.2.4.1. Arrhythmias
      • 4.2.4.2. Congestive Heart Failure
      • 4.2.4.3. Others
    • 4.2.5. By End-user
      • 4.2.5.1. Hospitals and Cardiac Centers
      • 4.2.5.2. Ambulatory Surgical Centers
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia-Pacific
      • 4.2.6.4. South America
      • 4.2.6.5. Middle East and Africa
    • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Implantability
    • 4.3.2. By Technology
    • 4.3.3. By Type
    • 4.3.4. By Indication
    • 4.3.5. By End-user
    • 4.3.6. By Region

5. North America Pacemaker Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Implantability
      • 5.2.1.1. Implantable
      • 5.2.1.2. External
    • 5.2.2. By Technology
      • 5.2.2.1. Single Chamber Pacemaker
      • 5.2.2.2. Dual Chamber Pacemaker
      • 5.2.2.3. Biventricular/CRT Pacemaker
    • 5.2.3. By Type
      • 5.2.3.1. Conventional
      • 5.2.3.2. MRI Compatible
    • 5.2.4. By Indication
      • 5.2.4.1. Arrhythmias
      • 5.2.4.2. Congestive Heart Failure
      • 5.2.4.3. Others
    • 5.2.5. By End-user
      • 5.2.5.1. Hospitals and Cardiac Centers
      • 5.2.5.2. Ambulatory Surgical Centers
    • 5.2.6. By Country Share
      • 5.2.6.1. United States
      • 5.2.6.2. Canada
      • 5.2.6.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Pacemaker Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Implantability
          • 5.3.1.2.1.1. Implantable
          • 5.3.1.2.1.2. External
        • 5.3.1.2.2. By Technology
          • 5.3.1.2.2.1. Single Chamber Pacemaker
          • 5.3.1.2.2.2. Dual Chamber Pacemaker
          • 5.3.1.2.2.3. Biventricular/CRT Pacemaker
        • 5.3.1.2.3. By Type
          • 5.3.1.2.3.1. Conventional
          • 5.3.1.2.3.2. MRI Compatible
        • 5.3.1.2.4. By Indication
          • 5.3.1.2.4.1. Arrhythmias
          • 5.3.1.2.4.2. Congestive Heart Failure
          • 5.3.1.2.4.3. Others
        • 5.3.1.2.5. By End-user
          • 5.3.1.2.5.1. Hospitals & Cardiac Centers
          • 5.3.1.2.5.2. Ambulatory Surgical Centers
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Pacemaker Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Pacemaker Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Pacemaker Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Pacemaker Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Medtronic plc
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Abbott Laboratories
    • 21.3.3. BOSTON SCIENTIFIC CORPORATION
    • 21.3.4. BIOTRONIK SE & Co KG
    • 21.3.5. Lepu Medical Technology (Beijing) Co., Ltd.
    • 21.3.6. OSYPKA MEDICAL GmbH
    • 21.3.7. MEDICO S.R.L.
    • 21.3.8. MicroPort Scientific Corporation
    • 21.3.9. Shree Pacetronix Ltd.
    • 21.3.10. LivaNova PLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer